ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

UCB, Inc. 

1950 Lake Park Drive

Smyrna  Georgia  30080  U.S.A.
Phone: 770-437-5705 Fax: 770-437-5640


SEARCH JOBS




Collaborations

The Medicines Company  Contract manufacturing of Bivalirudin peptide active ingredient

Praecis Pharmaceuticals Incorporated  Contract manufacturing of Abarelix peptide active ingredient

Amgen  Contract manufacturing of Abarelix peptide active ingredient

Bausch & Lomb  Contract manufacturing of active pharmaceutical ingredient





 Company News
UCB, Inc. (UCBJF.PK)-sponsored Data On Cimzia® (certolizumab pegol) To Be Highlighted At American College of Gastroenterology 2014 Annual Scientific Meeting 10/22/2014 11:15:01 AM
MC10 & UCB, Inc. (UCBJF.PK) Partner For Innovative Solutions For Patients With Neurological Disorders 7/28/2014 8:59:03 AM
Wilex AG (WL6.DE) Sends Back Some Promising Drugs To UCB, Inc. (UCBJF.PK) In Effort To Stay Alive 5/22/2014 7:36:33 AM
UCB, Inc. (UCBJF.PK) Announces Data From First Seven Year Evaluation Of Cimzia® (Certolizumab Pegol) In Moderate To Severe Crohn's Disease Patients 5/5/2014 8:54:03 AM
Sanofi (France) (SAN.PA), UCB, Inc. (UCBJF.PK) Strikes $138 Million Pact To Seek Anti-Inflammatory Small Molecules 3/11/2014 7:39:07 AM
UCB, Inc. (UCBJF.PK) CEO Out, Biopharma Chief Appointed To Top Post 2/20/2014 7:25:06 AM
UCB, Inc. (UCBJF.PK) And UK's MRC Technology Sign Exclusive License Agreement For A Fibrosis Program 2/13/2014 9:48:29 AM
Biogen, Inc. And UCB, Inc. (UCBJF.PK) Enter Agreements To Commercialize Multiple Sclerosis And Hemophilia Therapies In Asia 1/30/2014 11:56:57 AM
InteRNA Technologies, UCB, Inc. (UCBJF.PK) And University of Bonn To Collaborate On The Role Of MicroRNAs In Neurodegenerative Disease 1/10/2014 9:04:55 AM
Amgen (AMGN), UCB, Inc. (UCBJF.PK): Osteoporosis Phase 2 Drug Trial A Success 1/2/2014 6:35:53 AM
12345678910...